Lithium Ion

Lithium Ion

SCHEMBL7309260

CCCP(=O)([O-])NC(Cc1ccccc1)C(=O)Nc1nc(CC(=O)[O-])cs1.[Li+].[Li+]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MME P08473 5/20 0.47
PDE5A O76074 2/20 0.43
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
GPR142 Q7Z601 1/20 0.41
ALDH1A1 P00352 1/20 0.40
TP53 P04637 2/20 0.40
MAPK1 P28482 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HSPA1A P0DMV8 1/20 0.39
HSPA5 P11021 1/20 0.39
HSPA9 P38646 1/20 0.39
HSPA2 P54652 1/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL7304536 0.91 MME (0.42) MMEPDE5AMEN1KMT2AALDH1A1
SCHEMBL7298742 0.89 MME (0.46) MMEPDE5AMEN1KMT2AALDH1A1
SCHEMBL7305542 0.88 LMNA (0.53) ALDH1A1TP53NPC1HTTRAB9A
Lithium Ion SCHEMBL7306311 0.88 MEN1 (0.44) MMEPDE5AMEN1KMT2AALDH1A1
SCHEMBL7308785 0.76 MME (0.44) MMEPDE5AALDH1A1TP53MAPK1
SCHEMBL7301785 0.76 LMNA (0.52) ALDH1A1TP53MAPK1NPC1HTT
SCHEMBL7298781 0.74 MME (0.55) MMEPDE5AALDH1A1HSPA1AHSPA5
SCHEMBL7307895 0.73 LMNA (0.55) MEN1KMT2AALDH1A1TP53NPC1
SCHEMBL7302170 0.73 MME (0.54) MMEPDE5AALDH1A1HSPA1AHSPA5
Lithium Ion SCHEMBL7297039 0.72 KDM4A (0.41) GPR142ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0636630-B1 N-heteroaryl substituted derivatives of propanamide useful in the treatment of cardiovascular diseases ZAMBON SPA (IT) 1999-04-28 EP disclosed
US-5438046-A Enzyme inhibitors ZAMBON GROUP S.P.A. (IT) 1995-08-01 US disclosed
EP-0636630-A1 N-heteroaryl substituted derivatives of propanamide useful in the treatment of cardiovascular diseases ZAMBON GROUP S.p.A. (IT) 1995-02-01 EP disclosed